These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18956354)

  • 1. [Safer sex under antiretroviral therapy/].
    Winckler T
    Pharm Unserer Zeit; 2008; 37(6):446-7. PubMed ID: 18956354
    [No Abstract]   [Full Text] [Related]  

  • 2. Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy.
    Wilson DP
    AIDS; 2009 Jul; 23(11):1431-3. PubMed ID: 19487904
    [No Abstract]   [Full Text] [Related]  

  • 3. Highly active antiretroviral therapy in HIV-associated pulmonary hypertension.
    Barbaro G; Lucchini A; Barbarini G
    Minerva Cardioangiol; 2005 Apr; 53(2):153-4. PubMed ID: 15986010
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV sexual transmission under HAART: Project Inform comments on 2008 Swiss Statement.
    Dalton P; McCord A
    Proj Inf Perspect; 2008 Sep; (46):26-8. PubMed ID: 19048681
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased cardiovascular risk in patients with human immunodeficiency virus infection under highly active antiretroviral therapy.
    Zangerle R; Fuchs D
    Am J Cardiol; 2008 Aug; 102(3):373-4. PubMed ID: 18638612
    [No Abstract]   [Full Text] [Related]  

  • 6. Highly active antiretroviral therapy: a treatment for cutaneous polyarteritis nodosa-like syndrome in a HIV positive patient?
    Lai-Cheong JE; Tang V; Mazhude C; Baker L; Menagé Hdu P
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1138-40. PubMed ID: 17714158
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating primary HIV infection: HIV and the US sex-film industry.
    Laurence J
    AIDS Read; 2004 Jun; 14(6):280, 285. PubMed ID: 15243963
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitiligo in a patient associated with human immunodeficiency virus infection and repigmentation under antiretroviral therapy.
    Seyedalinaghi SA; Karami N; Hajiabdolbaghi M; Hosseini M
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):840-1. PubMed ID: 19453806
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous and pulmonary sarcoidosis in a patient with HIV after highly active antiretroviral therapy.
    Roustan G; Yebra M; Rodriguez-Braojos O; Baños I; Jaurena J; Simón A
    Int J Dermatol; 2007 Jan; 46(1):68-71. PubMed ID: 17214725
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular disease and HIV.
    Havlik R
    GMHC Treat Issues; 2007; 21(2):5-7. PubMed ID: 18411476
    [No Abstract]   [Full Text] [Related]  

  • 11. Smoldering myeloma in HIV patient: a complete remission after antiretroviral therapy.
    Sorli ML; Gimeno E; Abella E; Besses C; Knobel H
    Leuk Res; 2008 Sep; 32(9):1482-3. PubMed ID: 18221995
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric highly active antiretroviral therapy in Africa: potential benefits of a family-centered model.
    Reddi A; Leeper SC; Sunpath H
    J Infect Dis; 2008 Sep; 198(6):938-9; author reply 939-40. PubMed ID: 18721063
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in patients coinfected with hepatitis B virus and HIV: could antiretroviral therapy make a difference?
    Jain MK
    Clin Infect Dis; 2009 Jun; 48(12):1772-4. PubMed ID: 19435435
    [No Abstract]   [Full Text] [Related]  

  • 15. Vacuolar myelopathy: a case report of functional, clinical, and radiological improvement after highly active antiretroviral therapy.
    Bizaare M; Dawood H; Moodley A
    Int J Infect Dis; 2008 Jul; 12(4):442-4. PubMed ID: 18082439
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
    Nakimuli-Mpungu E; Musisi S
    AIDS Behav; 2009 Oct; 13(5):969-72. PubMed ID: 19662522
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-infections. Some good news about HAART and liver health.
    TreatmentUpdate; 2008; 20(4):8. PubMed ID: 19248274
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Szczech LA
    Curr Opin HIV AIDS; 2009 May; 4(3):167-70. PubMed ID: 19532045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What happens to children growing up with HIV infection? It's time for a HAART to heart.
    Viganò A; Pattarino G; Cerini C; Zuccotti GV
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):495-8. PubMed ID: 19485788
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of anxiety symptoms on adherence to highly active antiretroviral therapy in HIV-infected women.
    Roux P; Carrieri MP; Michel L; Fugon L; Marcellin F; Obadia Y; Spire B
    J Clin Psychiatry; 2009 Sep; 70(9):1328-9. PubMed ID: 19818261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.